Adjuvant high-dose rate brachytherapy with or without external beam radiotherapy post-hysterectomy for endometrial cancer

International Journal of Gynecological Cancer

Volumn 9, Issue 3, 1999, Pages 247-255

  Macleod, C ^a   Fowler, A ^a   Duval, P ^b   D'Costa, I ^c   Dalrymple, C ^a   Elliott, P ^a   Atkinson, K ^a   Firth, I ^a   Carter, J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Brachytherapy; Endometrial cancer; External beam; High dose rate; Radiotherapy

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; ENDOMETRIUM CANCER; FEMALE; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; TUMOR VOLUME;

EID: 0032970106     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1999.99026.x     Document Type: Article

References (33)

1. Carey MS, O'Connell GJ, Johanson CR et al. Good outcome associated with a standardized protocol using selective postoperative radiation in patients with Clinical Stage I adenocarcinoma of the endometrium. Gynecol Oncol 1995; 57: 138-44.
2. Orr JW, Holiman JL, Orr PF. Stage I corpus cancer: Is teletherapy necessary? Am J Obstet Gynecol 1997; 76: 777-87.
3. Mohan DS, Samuels MA, Selim MA et al. Long-term outcomes of therapeutic lymphadenectomy for Stage I endometrial adenocarcinoma. Gynecol Oncol 1998; 70: 165-71.
4. Podartz KC, Mariana A, Webb MJ. Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol 1998; 70: 163-4.
5. Berlinson JL, Lee KR, Badger GL, Pretorius RG, Jarrell MA. Clinical stage I adenocarcinoma of the endometrium - Analysis of recurrences and potential benefits of staging lymphadenectomy. Gynecol Oncol 1992; 44: 17-23.
6. Rush S, Gal D, Potters L, Bosworth J, Lovecchio J. Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma. Int J Radiant Oncol Biol Phys 1995; 33: 851-4.
7. Eltabbakh GH, Piver MS, Hempling RE, Shin KH. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk Stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal lymph node sampling: Report of a prospective study. Int J Radiat Oncol Biol Phys 1997; 38: 373-80.
8. Joslin CA, Vaishampayan GV, Mallik A. The treatment of early cancer of the corpus uteri. Br J Radiol 1977; 50: 38-45.
9. Sorbe BG, Smeds AC. Post-operative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma Stage I. Int J Radiat Oncol Biol Phys 1990; 18: 305-14.
10. Lybeert MLM, Putten WLJ, Ribot JG, Crommelin MA. Endometrial carcinoma: High dose-rate brachytherapy in combination with external irradiation: A multi-variate analysis of relapses. Radiother Oncol 1989; 16: 145-252.
11. Nori, D, Merimsky O, Batata M, Caputo T. Postoperative high dose rate brachytherapy combined with external irradiation for early stage endometrial cancer: A long term follow-up. Int J Radiat Oncol Biol Phys 1994; 30: 831-7.
12. Fanning J, Nanavati PJ, Hilgers RD. Surgical staging and high dose rate brachytherapy for endometrial cancer: Limiting external radiotherapy to node-positive patients. Obstet Gynecol 1996; 6: 1041-4.
13. Noyes WR, Bastion K, Edwards SA et al. Postoperative vaginal cuff irradiation using high dose rate remote afterloading: A phase II clinical protocol. Int J Radiat Oncol Biol Phys 1995; 32: 1439-43.
14. Gumbs AA, Turner BC, Knisely JPS et al. Post-operative high dose rate vaginal apex brachytherapy in Stage I endometrial adenocarcinoma (Abstract No. 2101 from the 38th ASTRO Proceedings). Int J Radiat Oncol Biol Phys 1996; 36: 327.
15. Knocke TH, Tatzeiter G, Baldass M et al. Results of postoperative irradiation in patients with high risk endometrial cancers (Abstract No. 258). Radiother Oncol 1998; 48: S66.
16. MacLeod C, Fowler A, Duval P et al. High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer. Int J Radiat Oncol Biol Phys 1998; 42: 1033-9.
17. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-6.
18. Murrell DS, Orton CG. Survival and complications in Stage I corpus uteri receiving post-operative irradiation. Radiother Oncol 1988; 12: 281-8.
19. Jereczek-Fossa B, Jassem J, Nowak R, Badzio A. Late complications after post-operative radiotherapy in endometrial cancer: Analysis of 317 consecutive cases with application of linear-quadratic model. Int J Radiat Oncol Biol Phys 1998; 41: 330-8.
20. Landoni F, Maneo A, Colombo A et al. Randomised study of radical surgery versus radiotherapy for IB-IIA cervical cancer. Lancet 1997; 350: 535-40.
21. Perez CA, Grigsby PW, Camel HM et al. Irradiation alone or combined with surgery in Stage IB, IIA and IIB carcinoma of the cervix: Update of a non-randomized comparison. Int J Radiat Oncol Biol Phys 1995; 31: 703-13.
22. Potish RA, Dusenbury KA. Enteric morbidity of postoperative pelvic external beam and brachytherapy for uterine cancer. Int J Radiat Oncol Biol Phys 1990; 18: 1005-10.
23. Barendsen GW. Dose fractionation, dose rate and isoeffect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982; 8: 1981-97.
24. Fowler JF. Brief summary of radiobiological principles in fractionated radiotherapy. Semin Radiol Oncol 1992; 2: 16-21.
25. Nag S, Abitol AA, Anderson LL et al. Consensus guidelines for high dose rate remote brachytherapy in cervical, endometrial, and endobronchial tumours. Int J Radiat Oncol Biol Phys 1993; 27: 1241-4.
26. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial cancer. Obstet Gynecol 1980; 56: 419-26.
27. Elliott P, Green D, Coates A et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer 1994; 4: 84-93.
28. Roberts JA, Brunetta CL, Keys HM et al. A phase III randomized trial of surgery versus surgery plus adjuvant radiation therapy in intermediate risk endometrial adenocarcinoma (GOG 99) (Abstract No. 35). Twenty-ninth Annual Meeting of the Society of Gynecologic Oncologists. : Society of Gynecologic Oncologists. Orlando, FL. 1998;70.
29. Creutzberg CL, van Putten WLJ, Koper PCM et al. Post-operative radiotherapy in PTI endometrial carcinoma: Results from a prospective randomized trial in 715 patients (Abstract No. ). Radiother Oncol 1998; 48: S78.
30. Greven KM, Agostino RB, Lanciano RM, Corn BW. Is there a role for a vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer? Int J Radiat Oncol Biol Phys 1998; 42: 102-4.
31. Randall ME, Wilder J, Greven K, Raben M. Role of intracavity boost after adjuvant external irradiation in early endometrial cancer. Int J Radiat Oncol Biol Phys 1990; 19: 49-54.
32. Konski AA, Bracy PM, Jurs SC, Weiss SJ, Zeider SR. Cost minimization analysis of various treatment options for Surgical Stage I endometrial cancer. Int J Radiat Oncol Biol Phys 1997; 37: 367-72.
33. Pinella J, Gynecology Tumor Board. Cost minimization of high-dose-rate versus low-dose-rate brachytherapy in endometrial cancer. Int J Radiat Oncol Biol Phys 1998; 41: 88-90.